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Abstract
Despite monolayer cultures being widely used for cancer drug development and testing, 2D cultures tend to be
hypersensitive to chemotherapy and are relatively poor predictors of whether a drug will provide clinical benefit. Whilst
generally more complicated, three dimensional (3D) culture systems often better recapitulate true cancer architecture and
provide a more accurate drug response. As a step towards making 3D cancer cultures more accessible, we have developed a
microwell platform and surface modification protocol to enable high throughput manufacture of 3D cancer aggregates.
Herein we use this novel system to characterize prostate cancer cell microaggregates, including growth kinetics and drug
sensitivity. Our results indicate that prostate cancer cells are viable in this system, however some non-cancerous prostate
cell lines are not. This system allows us to consistently control for the presence or absence of an apoptotic core in the 3D
cancer microaggregates. Similar to tumor tissues, the 3D microaggregates display poor polarity. Critically the response of 3D
microaggregates to the chemotherapeutic drug, docetaxel, is more consistent with in vivo results than the equivalent 2D
controls. Cumulatively, our results demonstrate that these prostate cancer microaggregates better recapitulate the
morphology of prostate tumors compared to 2D and can be used for high-throughput drug testing.
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Introduction
Three-dimensional (3D) cell culture is motivated by the need to
carry out experiments that better recapitulate the physiological
microenvironment. Conventional two dimensional (2D) cell
cultures often fail to mimic the cellular functions and signaling
pathways present in tissue. Consequently 2D cell cultures can lead
to skewed and limited data [1,2]. Microarray profiling of 2D
versus 3D cultures has shown that 50% of genes change in
expression upon 3D culture [3]. Some of these differences may be
attributed to differences in the mechanical tension of the matrix.
For instance, cells cultured in 2D on tissue culture plastic
experience elevated tensile stress, a million times greater than
that of soft tissue [4], and this is known to alter cell physiology [5].
Artificially high tensile stresses can profoundly affect cell
morphology, cytoskeleton arrangement, cell-cell adhesion and
migration. 3D-cultures better mimic natural tissue mechanical
stresses and thus provide a more representative pathophysiological
condition than using conventional tissue culture plates [6,7]. This
relative effect is apparent during in vitro chemotherapy testing,
where 2D cultures are typically hypersensitive to drugs whilst 3D
culture drug sensitivity more often parallels the equivalent in vivo
scenario [8,9].
Despite the fact that 3D-cultures function as more robust in
vitro cancer drug testing models, most laboratories still rely on 2D
cultures as their primary tool. This is partly due to the increased
labor and costs associated with establishing 3D models and
because there is no agreement on a single standard model which
could be used across the field. Several types of 3D culture systems,
with different advantages and pitfalls, are currently employed.
Natural extra-cellular matrix (ECM) gels such as type-I collagen
and laminin-rich Matrigel can provide the mechanical and
chemical cues for tissue morphogenesis, however, they contain a
number of undefined growth factors and ECM proteins that differ
between batches changing the mechanical properties of the gel.
Synthetic gels comprised of peptide-functionalized synthetic
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polymers are tailored to mimic specific ECM properties and
therefore offer an alternative [10]. However, scaffold and gel based
systems can be expensive to scale up into large high-throughput
studies and difficult to analyze. Techniques such as liquid-agar
overlay and polyhema offer a cheaper alternative, however the size
and uniformity of the aggregates cannot be strictly regulated and
this would translate to different drug penetration rates [11,12]. We
have adapted a high throughput microwell system to culture
prostate cells as microaggregates of a controlled size. This system
offers an advantage over other 3D culture systems in that the
dimensions of the microaggregates can be strictly regulated and
aggregates of a defined size are produced of a scalable nature for
high-throughput drug testing. Herein we show that prostate cancer
cells self-assemble into aggregates that respond to drug treatment
in a manner consistent with the expected in vivo sensitivity.
Materials and Methods
Fabrication and multi-layering of the microwells
The fabrication of the polydimethylsiloxane (PDMS) microwell
arrays was performed as described previously [13]. In this instance
we used soft lithography to form arrays of 36063606180 mm
microwells or 80068006800 mm on PDMS discs, which were
then mounted into the wells of a 48-well tissue culture plate.
Briefly, a silica wafer was used to form a PDMS mold, from which
an inverse polystyrene mold was created. The PDMS microwell
surface was created in sheets using the latter mold and the sheet
was punched out into discs (Figure 1A). Punches of differing sizes
can be used to create inserts for any sized tissue culture plastic
vessel. Using this technique thousands of microwells can be
produced en masse (600 microaggregates/cm2 or 150 microag-
gregates/cm2 for the smaller and larger microwells, respectively).
The PDMS surface was either coated with 5% pluronic/
phosphate buffered saline (PBS) solution or multilayered with
chitosan (CHI) and hyaluronic acid (HA), both of which prevent
cell adhesion to the PDMS surface. As described previously [13]
multi-layering begins with an electropositive poly-lysine layer to
aid further layer adhesion and five layers of CHI and HA are
sequentially incubated for 15 minute intervals. We have previously
shown that the upper HA layer blocks cell adhesion on PDMS
microwells and that this promotes cell aggregation [14]. After
coating the inserts were sterilized in 70% ethanol and washed
overnight with PBS ready for use.
Cells and prostate microaggregate culture
The prostate cancer cell lines, RWPE-2 [15] and LNCaP [16],
and non-cancerous cells line RWPE-1 [15], were obtained from
the American Type Culture Collection (ATCC). Cells were
cultured in RPMI 1640, 5% fetal bovine serum (FBS) (Gibco)
plus 1% penicillin/streptomycin (P/S)(Gibco) in 5% CO2 at 37uC.
For medium optimization studies, Keratinocyte-SFM, 2% Bovine
Pituitary Extract (BPE), plus epidermal growth factor (EGF)
supplement (Gibco) was also used. Either 50,000 or 100,000 cells
were seeded per well in 1 mL of culture medium. Microaggregates
were formed through forced aggregation; the plates were
centrifuged at 1000 rpm for 5 min to facilitate pelleting of the
cells into the microwells. In the forced aggregation process, the
cells suspended in the medium are uniformly pelleted within the
array of microwells at the base of the well. Medium was exchanged
on days 3, 6, 8, 10, and 13. During the medium exchange, care
was taken not to aspirate the microaggregates. Medium was added
and subtracted from the same point in the well during each
exchange. Plates were incubated at 37uC with 5% CO2. Phase
contrast images were taken using a Nikon Eclipse-Ti inverted
microscope and the central diameter of each microaggregate was
measured using Image-J software (http://rsbweb.nih.gov/ij/). A
minimum of 50 microaggregates were measured per time-point.
Sectioning, immunofluorescence and confocal imaging
Microaggregates were fixed with 4% paraformaldehyde (PFA)
for 30 mins and either embedded in Tissue-Tek optimal cutting
temperature (OCT) compound (VWR International) for section-
ing or immunostained directly. Samples were permeabilized with
0.5% Triton-X 100 for 20 min and incubated with primary
antibodies for E-Cadherin (Invitrogen, AB_86564), b-catenin
(Santa-Cruz, AB_626807) (diluted 1:200), a6-integrin (Millipore,
AB_10834933), laminin-5 (Abcam, AB_2133782), cleaved cas-
pase-3 (Cell Signalling Technology, AB_331440) (diluted 1:100)
and Ki67 (Abcam, AB_443209) (1:400) overnight at 4uC. The
respective secondary antibody conjugated to alexa-488 (Invitro-
gen) was added for 1 hr at room temperature; 4’,6-diamidino-2-
phenylindole (DAPI, Sigma-Aldrich) was used to stain the nuclei
and Rhodamine Phalloidin (Invitrogen) was used to stain for F-
actin. The microaggregates were mounted using Prolong gold
(Invitrogen) and imaged using a Leica TCS SP5 confocal
microscope or a Nikon Eclipse-Ti inverted microscope.
Live/dead staining
Cells were incubated with 2 mg/mL fluorescein diacetate (FDA)
(Sigma-Aldrich) for 15 mins and 20 mg/mL propidium iodide (PI)
(Sigma-Aldrich) for 2 mins at 37uC to stain live and dead cells
respectively. FDA is a cell-permeable esterase substrate that
measures both enzymatic activity and cell-membrane integrity.
Propidium iodide binds to DNA, but is only able to penetrate the
compromised membranes of dead or dying cells. Cells were
imaged using a Leica TCS SP5 confocal microscope and the
percentage area of dead cells per microaggregate was quantified
using Image-J software (http://rsbweb.nih.gov/ij/). A minimum
of 10 microaggregates were analyzed per time-point.
Alamar blue and WST-1 cell viability assays
To establish cell metabolism over 14 days of microaggregate
growth, the Alamar blue (Invitrogen) assay was used as per the
manufacturer’s instructions. On days 1, 3, 7 and 14 a 3% volume
of Alamar blue was added per well. The plates were incubated at
37uC for 1 hr and 100 ml medium transferred to a 96-well black
plate. Fluorescence (excitation 544 nm, emission 590 nm) was
detected using a plate reader (BMG Omega, BMG LABTECH).
WST-1 (Roche) was used to quantify the viability of RWPE-1 and
RWPE-2 cells cultured in different medium types. Cells were
cultured for 3 days followed by the addition of 10% WST-1 for
1 hr before reading absorbance at 450 nm on a Bio-Rad
Benchmark Plus plate reader.
PicoGreen assay. The PicoGreen assay (Invitrogen) used as
a measure of viable cells by detecting total double stranded DNA,
was performed according to the manufacturer’s instructions.
Briefly, DNA was extracted with 0.5 mg/mL proteinase K
(Roche) phosphate buffered EDTA (PBE). Samples were diluted
(1:10) in RNaseA solution (Invitrogen) and incubated with
PicoGreen assay reagent before being read on a fluorescence
plate reader (BMG Omega, BMG LABTECH; excitation 485 nm
emission 520 nm).
Drug treatments
LNCaP cells were seeded in 48-well plates with or without
PDMS inserts and cultured for two days prior to treatment with
dilutions of 0.01–1000 nM docetaxel (Sigma-Aldrich) for 72 h,
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which were compared to a DMSO vehicle control. The protocol
for Alamar blue was adapted to read within the plate through the
clear PDMS insert by using 10% Alamar blue and incubating for
2 hrs. A serial dilution of cells showed that the fluorescence was
relative to cell number (R-squared value of 0.99; data not shown).
The IC50 was calculated using Calcusyn Statistics package
(Biosoft, UK) as reported previously [17].
3D culture of RWPE-1 cells in Matrigel basement
membrane matrix
RWPE-1 cells were cultured in Matrigel (BD Biosciences) for 7
days to assess polarity. This method has been used previously
[18,19]; briefly, RWPE-1 cells were seeded in either 1% or 8%
Matrigel in the presence of Keratinocyte-SFM medium supple-
mented with 2% BPE (Gibco). The polarity of cells grown in
Matrigel plus or minus microwell insert was compared.
Results and Discussion
The PDMS microwell system produces prostate cancer
microaggregates of uniform and controlled size
The purpose of this work was to produce a high-throughput
PDMS microaggregate system for the testing of therapeutic drugs
for prostate cancer. Initially, we sought to characterize the growth
of prostate cancer cells in the microwell system and compare the
morphology, and growth rate to normal cell counterparts. PDMS
is an inert polymer that is increasingly being used in tissue culture
applications [20]. It is suitable because it is inexpensive and
compatible with rapid fabrication methodology such as soft
lithography [21]. PDMS surfaces have been molded and utilized
in culture applications to control the shape and size of single cells
[22], and specifically microwells formed from PDMS have been
used to manufacture cell aggregates to enhance the differentiation
of human embryonic stem cells into neuronal cells [23,24] and
mesenchymal stem cells into osteoblasts or chondrocytes
[13,24,25]. This study is the first to culture prostate cells on a
PDMS microwell surface to controlled aggregate size. Prostate
cancer cells were cultured as 3D aggregates of strictly controlled
dimensions using a PDMS micro-surface comprised of 600 micro-
wells/cm2, each being 360 mm by 360 mm (Figure 1A). The
microwell surface was modified with either 5% pluronic or multi-
layered (Figures 1B and C). Both surface coatings blocked
surface cell adhesion and promoted microaggregate formation.
Aggregates formed from LNCaP cells remained viable and
increased in metabolism over 7 days at rates comparable to cells
grown in 2D culture (Figures 1B and C). At day one, after
50,000 cells were seeded, LNCaP cells formed uniform microag-
gregates of 70 mm diameter (Figure 2A). Over a 7 day culture the
aggregates uniformly grew to be 120 mm diameter. This appeared
to be a limiting diameter and the size did not substantially increase
with further culture (Figure 2A). RWPE-2 cells formed signifi-
cantly smaller aggregates of 60 mm at day one, and the
microaggregates did not increase in diameter over 14 days
(Figure 2A). The diameter of the RWPE-1 cells was not
measured as the aggregates were unstable, disassociating into
loose clusters of cells after three days in culture. RWPE-1 and
RWPE-2 cells were cultured in RPMI 5% FBS+PS instead of their
recommended growth medium, Keratinocyte-SFM, in order to
optimize microaggregate formation. In the latter medium the
RWPE-1 and RWPE-2 cells formed dispersed clusters of cells with
a high proportion of dead cells after 7 days (Figure S1A).
Alteration of the growth medium had no significant adverse effects
Figure 1. Fabrication of the PDMS micro-patterned surface system and surface coating with pluronic or multi-layering. (A) A
polystyrene mold [13], was used to cast PDMS sheets with a micro-patterned surface. Discs were punched out of the PDMS sheet to form inserts for
multiwell plates, and these surfaces were coated with either 5% pluronic or multilayered with CHI and HA. LNCaP cells (50,000) were seeded on to
either (B) pluronic coated (3D pluronic) or (C) multi-layered (3D multi) microwells and the Alamar blue assay was used to measure metabolism in 3D
versus 2D cells. Both coatings produced viable aggregates that increased in metabolism over 7 days at a comparable rate to cells grown in 2D culture.
Three technical replicates were carried out per time-point.
doi:10.1371/journal.pone.0111029.g001
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on the cell metabolism compared to the recommended medium
(Figure S1B). Therefore, RPMI 1640, 5% FBS+P/S was used in
all further experimentation.
Prostate cancer cells are viable in the PDMS microwell
system and have a lower proliferation rate relative to
monolayer
The viability of the prostate microaggregates was assessed over
14 days by calculating the percentage of dead cells with respect to
the live cells (Figure 2B) from FDA/PI stained microaggregate
confocal images (Figure 2C). The FDA dye results show that the
prostate cancer cell types, LNCaP and RWPE-2, have an intact
cell membrane over 14 days. In contrast, the non-cancerous cell
line, RWPE-1 shows a proportional increase in lysed cell
membranes over 14 days and display loose organization (day 14
phase). Correspondingly, LNCaP microaggregates demonstrate an
increase in metabolism over 14 days (Figure 3A) and an increase
in DNA content (Figure 3B). However, RWPE-2 microaggre-
gates show a clear decrease in metabolism (Figure 3C) and a
decrease in DNA content (Figure 3D) despite having intact
cellular membranes according to the FDA staining (Figure 2B).
Therefore, the RWPE-2 cells are likely to be in a dormant cell
state, without cell division or cell death. This is supported by the
microaggregate sizing data, which shows that RWPE-2 microag-
gregates did not significantly increase in diameter (Figure 2A).
For the RWPE-2 cell 2D data, there was a weak correlation
between the assays, despite the clear correlation between the
assays for the 3D data; in 2D the metabolism declined after day 3
(Figure 3C), however the DNA content continued to increase
until day 14 (Figure 3D). This indicates that the cells were still
able to divide and were therefore not nutrient starved, but shows
poor correlation between these assays, which has been previously
documented [26]. Nonetheless, the LNCaP PicoGreen data did
correlate well with the Alamar blue metabolic data (Figure 3A
and B). Overall, the metabolism and proliferation of all cells was
lower in 3D compared to monolayer (Figure 3), which is
consistent with previous studies [9]. The 2D surface provides a
large surface area for attachment, which is a pre-requisite for
Figure 2. The PDMS microwell system produces prostate cancer cell aggregates that are viable and of a controlled size. (A) The
diameters of LNCaP and RWPE-2 cell aggregates were measured over 14 days; mean +/- SD, n = 50 from *p,0.05, a paired students t-test was used to
show significant differences in diameter at day 7 and 14. (B) FDA/PI stain was used to stain viable cells green and dead cells red on the days shown
and the percentage area of dead cells per microaggregate has been quantified to show that the non-cancer prostate cells (RWPE-1) have greater cell
death (percentage red pixels) in the microwell inserts compared to the prostate cancer cells (LNCaP and RWPE-2); mean +/- SD, n = 10. A paired
students t-test was used to calculate significance*p,0.05. (C) The confocal images and phase contrast images (Day 14 Phase) show that prostate
cancer cell lines (RWPE-2 and LNCaP) grow as compact smooth microaggregates until day 14. Conversely, the non-cancer cells (RWPE-1) form
dispersed loose clusters which are non-viable and with no definable diameter at day 14. Scale bar is 100 mm.
doi:10.1371/journal.pone.0111029.g002
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successful cell division i.e. focal adhesion anchor points are
provided for the dividing cells, which are necessary for prolifer-
ation [27]. However, this gives a false representation of the
division rate in a tissue and the lower 3D replication rate is more
analogous to proliferation rates in tumors.
Prostate cell lines grown as microaggregates display
poor polarity similar to tumors
Microaggregates were fixed at day 7 and immunostained for
apical (E-Cadherin and b-catenin) and basal (a6-integrin and
laminin-5) markers of 3D polarity (Figure 4). These markers were
selected according to their previous use as apical and basal surface
markers in 3D matrix systems [18,28–30]. From this data, it is
clear that all microaggregates did not have a hollow lumen and did
not form polar structures, with only Laminin-5 being observed in a
position expected for a polar aggregate, which was on the basal
surface on the outer edge of the microaggregate (Figure 4 LM-5).
In order to check that the antibodies were working cell lines
cultured in monolayer were also immunostained for the same
polarity markers and imaged using confocal Z-sectioning (Figure
S2). As expected, Laminin 5 and a6-integrin stain the basal
surface of all cell types grown in monolayer, with some
cytoplasmic staining (Figure S2B black arrows). and E-Cad
and b-catenin are predominantly expressed at the cell to cell
junctions (Figure S2B white arrows). Polar 3D microaggre-
gates or spheroids are defined by an apical surface that surrounds
a hollow lumen and a basal surface that would attach to the
surrounding matrix [18]. The microwell system is devoid of
matrix, apart from any cell secreted soluble matrix proteins and
there is no scaffold for attachment and hence lack of a clear basal
surface. Therefore, it is predictable that the microaggregates lack a
hollow lumen and thus an apical surface as matrix tension
contributes to tissue organization [31], however some degree of
cell organization exsists. For example, LNCaP, RWPE-1 and 2
cells express Laminin-5 on the outer aggregate surface, but do not
express a6-integrin. In addition, E-cadherin and b-catenin were
found expressed between the cell adhesions of LNCaP and
RWPE-2 microaggregates (Figure 4), but there is no luminal
surface and hence there is no expression of these markers at an
apical surface. Thus, the cells are able to express these phenotypic
markers but require other cues, likely from an extracellular matrix
or surrounding cells such as would be present in the tumor
microenvironment, to form organized tissue acini [32]. Although
there are no clear differences between the cancer and non-cancer
cells lines, the phenotype observed is more indicative of the de-
differentiated cancer cell observed in high grade prostate cancer
indicating that the assay is still suitable for high throughput drug
testing of prostate cancer cells. However, this system is not viable
for the culture of non-neoplastic cell lines due to the absence of
matrix. But with the addition of Matrigel to the PDMS microwell
system, the normal prostate cell line, RWPE-1, formed aggregates
that displayed polarity (Figure S3A and S3B). With the addition
of 8% Matrigel the RWPE-1 aggregates displayed polar organi-
zation with the basal expression of a6-integrin (Figure S3B) and
Figure 3. LNCaP microaggregates are metabolically active and proliferative over 14 days; whereas RWPE-2 microaggregates are
metabolically dormant and non-proliferative. The viability of LNCaP (A and B) and RWPE-2 (C and D) microaggreagtes versus the same number
of cells cultured in 2D was assessed via Alamar blue (A and C) and PicoGreen assay (B and D). LNCaP microaggregates demonstrate an increase in
metabolism over 14 days (A) and an increase in DNA content (B). However, RWPE-2 microaggregates show a decrease in metabolism (C) and a
decrease in DNA content (D). Mean +/- SD; n = 4. Data represents three experiments. *p,0.05, a paired students t-test was used to determine
significance between 2D and 3D.
doi:10.1371/journal.pone.0111029.g003
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this polarity was maintained with 1% Matrigel (Figure S3A).
However, the microaggregates grown in PDMS inserts with
Matrigel were larger compared to those grown on inserts alone
(Figure S3C) or in 8% Matrigel alone (Figure S3D). Therefore,
the addition of Matrigel provides a matrix to induce a6-integrin
polarity, which was lost in RWPE-1 cells cultured on modified
PDMS alone. Alpha-6-integrin has been shown to be important
for acinus formation in RWPE-1 cells [33], thence the lack of a6-
integrin may contribute to the poor microaggregate formation
displayed by normal RWPE-1 cells.
The PDMS microwell system can be used to control
apoptotic core
LNCaP cells cultured in the microwell system (3606360 mm),
which reach a maximum size of 120 mm do not form an apoptotic
core as identified by cleaved caspase-3 staining at day 7
(Figure 5A). However, apoptotic core can be controlled for by
increasing the size of the micro-well to 800 mm and increasing the
seeding cell number to 2000 cells per aggregate. This created
aggregates of,300 mm in diameter over 7 days with a central core
of cleaved caspase-3 staining (Figure 5B). An apoptotic core is
usually observed in 3D cultures of larger than 500 to 600 mm
diameter [34–36] however apoptotic cores have been observed
even in LNCaP cell aggregates of 200 mm diameter [37]. The
variation in observations reflect the fact that effective oxygen
delivery is a function of many variables including total culture cell
number, and height of the medium as well as aggregate diameter
[38]. In our studies we inoculated the larger diameter aggregates
with 6 fold greater cell numbers than the smaller aggregates, and
because of the cubic relationship in the volume radius equation
(V=4/3pr3) this resulted in just less than a doubling of the
aggregate diameter (Figure 5C). Proliferating cells have previ-
ously been shown to be concentrated at the periphery of LNCaP
aggregates of 200 mm grown using the agar liquid overlay
technique [36]. In our study we used Ki67 staining to reveal that
proliferating cells could be found evenly throughout the aggregate
and that these cells were not concentrated in any one particular
area (Figure 5D), perhaps due to the absence of a basal surface
provided by a matrix surface. Therefore, we have demonstrated
that we can control for apoptotic core using differently sized
microwells and that proliferation is evenly distributed throughout
the microaggregates.
Figure 4. The microaggregates lack polarity as would be observed in a tumor.Microaggregates were fixed at day 7 and immunostained for
apical and basal polarity markers (green). E-Cadherin (E-Cad) and b-catenin were used as apical markers and the basal markers were a6-integrin (a6-
INT) and Laminin 5 (LM5). Nuclei were stained with DAPI (magenta) and the scale bar is 100 mm.
doi:10.1371/journal.pone.0111029.g004
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Culture of prostate cancer cells as 3D microaggregates
increases drug resistance, which is attributed to
differences in proliferation
LNCaP cells were cultured in 2D or the PDMS microwells for 2
days prior to drug treatment. Up to 1000 nM of docetaxel was
added and compared to a DMSO vehicle control. Docetaxel was
used as a representative cancer drug in this study due to its routine
use in prostate cancer treatment [39]. It prevents mitotic spindle
assembly and mitotic cell division, leading to apoptosis, by
decreasing the amount of free tubulin needed for microtubule
formation [39]. Cells cultured in 3D were more resistant to all
doses of docetaxel than those cultured in 2D after 48 hrs
(Figure 6A). At 72 hrs differences were only observed at the
high drug doses of 10 and 100 nM docetaxel (Figure 6B). With a
longer drug incubation time the IC50 increased for both 2D and
3D. For example in 2D at 48 hrs the IC50 was 11 nM and this
increased to 51.3 nM over 72 hrs. In 3D the IC50 was
exceptionally high indicating that the 3D microaggregates are
highly resistant to docetaxel, the calculated IC50 at 48 hrs was
4.36108 and 426 nM at 72 hrs. With increasing doses of docetaxel
the cells in 3D retained their aggregation, but became more
loosely associated, but in 2D the cells detached (Figure 6C). It has
been reported for several types of cancer that 3D cultures show
more resistance to chemotherapeutics [9,40] and that in 3D,
LNCaP cells are more resistant to docetaxel than their monolayer
counterparts [9]. In addition, we have shown that LNCaP cells
grown in 3D have lower replication compared to their 2D
counterparts (Figure 3B) and are thus more resistant to
docetaxel, which targets proliferating cells [41]. We have shown
that these effects are temporary and that when 7 day old
microaggregates are returned to a 2D plastic substrate as a single
cell suspension they exhibit the same dose response profile as cells
cultured in 2D (Figure S4). This drug penetration in 3D-systems
is slower compared to a single monolayer of cells, which makes it
more comparable to solid tumors [42]. Indeed drug penetration
into solid tumors is typically 5- to 10-fold slower than in monolayer
cultures [43].
Summary
In summary, the PDMS system can be used to regulate the
dimensions of cancer cell microaggregates to replicate different
stages of tumor growth. The microwell system produces prostate
cancer microaggregates of strictly controlled dimensions using a
PDMS micro-surface comprised of 600 micro-wells/cm2, each
Figure 5. Apoptotic core can be controlled for using differently sized microwells. (A) Cleaved caspase-3 (CASP3; green), an apoptosis
marker, was used to stain sections of RWPE-1, RWPE-2 and LNCaP microaggregates. (B) Due to the absence of cleaved caspase-3 in the small LNCaP
aggregates, a large microwell (800 mm6800 mm6800 mm) was used to create large LNCaP microaggregates with an apoptotic core (CASP3 Lge). (C)
The diameter of the LNCaP microaggregates (Sml) was compared with LNCaP microaggregates grown in the large microwells (Lge). A minimum of 50
aggregates were measured per condition. (D) Ki67 (green) was also used to stain proliferating cells within the large LNCaP aggregate. Nuclei were
stained with DAPI (magenta); scale bar is 100 mm.
doi:10.1371/journal.pone.0111029.g005
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being 360 mm by 360 mm. Surface modification with either 5%
pluronic or multi-layering blocks protein adsorption and cell
attachment onto the PDMS, and this promotes microaggregate
formation. LNCaP aggregates were viable and the cell number in
the aggregates increased over time. Apoptotic core in LNCaP cells
aggregates can be controlled by using either small (3606360 mm)
or large (8006800 mm) dimension microwells. The cancer
microaggregates, formed from LNCaP and RWPE-2 cells lack
polarity as would be observed in a tumor while the normal RWPE-
1 cells form a basal surface as identified by a6-integrin expression
after the addition of Matrigel matrix to the microwell plates. The
normal prostate cells, RWPE-1, cultured without matrix were not
viable in the system and 80% of the cells in 3D cultures had died
by day 14. This system can be used for high-throughput drug
testing for cancer cells in 3D. The small and large microwell
surfaces enable manufacture of 600 or 150 microaggregates per
cm2, respectively. A 96 well plate with the small microwell surface
enables the uniform manufacture ,34,000 microaggregates, and
this could be integrated with fluidics robotics to enable high
throughput drug testing. Using this system, we have shown that
LNCaP microaggregates are more resistant to docetaxel compared
to cells grown as monolayers and that when the microaggregates
are dispersed and returned to monolayer, they exhibit the same
dose response to docetaxel as those cells cultured in monolayer.
Future advances in the use of this technology include the addition
of stromal cell types including fibroblasts, mesenchymal stromal
cells, endothelium and osteoblasts to better mimic the tumor
microenvironment.
Supporting Information
Figure S1 The viability of RWPE-1 and RWPE-2 cells cultured
in keratincyte-SFM medium. (A) RWPE-1 and RWPE-2 cells were
grown in Keratinocyte-SFM+BPE+EGF+FGF (KSFM) over 7
days to observe the morphology and viability of the microaggre-
gates. The viability of RWPE-1 and RWPE-2 cells was determined
using FDA/PI staining and imaged using confocal microscopy
(upper panel) and phase contrast microscopy (Ph; lower panel).
Scale bar is 100 mm. (B) WST-1 cell proliferation assay was used to
determine metabolism of RWPE-1 and RWPE-2 cells grown in
different medium compositions. KSFM was compared to RPMI
1640+5% FBS (labeled as R5%), and a 1:1 ratio mix of both
media types. RPMI without serum (labeled as R) was used as a
negative control. Mean +/-SD; n= 4 *P,0.05.
(TIF)
Figure S2 Markers of spheroid polarity in monolayer. (A)
Monolayers of RWPE-1, RWPE-2 or LNCaP cells were fixed and
immunostained for apical (E-Cadherin/E-Cad and b-catenin) and
Figure 6. LNCaP microaggregates are more resistant to docetaxel compared to cells grown as monolayers. LNCaP cells (50,000 cells/
well) were treated with docetaxel over 48 hrs (A) or 72 hrs (B) at day 2 of growth either in 2D and 3D. Alamar blue was used to assess cell viability.
Mean +/- SE, n = 4 biological replicates *P,0.05; the data shown is representative of three independent experiments. (C) Phase contrast images show
the effects of docetaxel after 72 hrs on the morphology of the microaggregates (3D) compared to cells grown in monolayer (2D).
doi:10.1371/journal.pone.0111029.g006
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basal polarity markers (a6-integrin/a6-INT and laminin-5/LM-5)
(green). (B) Shows the confocal Z-projection of each of the stained
images. LM-5 and a6-INT stain the basal surface of all cell types
(black arrow heads), and LNCaP cells express LM-5 throughout
the cell cytoplasm. E-Cad and b-catenin are predominantly
expressed at the cell to cell junctions (white arrow heads) and on
the apical surface of all cell types. However, some basal staining
does occur. In all images nuclei are stained with DAPI (blue) and
F-actin was stained with Phalloidin (red). The scale bar is 100 mm.
(TIF)
Figure S3 3D culture of RWPE-1 cells in Matrigel basement
membrane matrix. RWPE-1 cells were cultured in either (A) 1%
or (B) 8% Matrigel (BD Biosciences) in the presence of
Keratinocyte-SFM medium supplemented with 2% BPE (Gibco)
for 7 days. The polarity of aggregates formed from microwell
inserts alone (C) or Matrigel alone (D) was compared. Micro-
aggregates were immunostained with a6-integrin (green), F-actin
(red) and DAPI (blue). The panel in D shows the magnified edge of
the microaggregate with Matrigel alone.
(TIF)
Figure S4 LNCaP cells grown as 3D microaggregates and
returned to tissue culture plastic respond the same way to
docetaxel as monolayer cells. LNCaP cells were seeded in 48-
well plates with PDMS inserts and cultured for 7 days prior to
being typsinized and re-plated in a 48-well plate without PDMS
insert. Fresh LNCaP cells, which had not been subjected to 3D
culture were plated at the same time. Two days post-seed cells
were treated with 0.01-1000 nM docetaxel (Sigma-Aldrich) for
72 h and viability read using Alamar blue assay. There was no
significant difference between the cells cultured in monolayer (2D)
and those that had previously been cultured as 3D microaggre-
gates (3D RS) n= 3, *p,0.05.
(TIF)
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